Literature DB >> 19793765

The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Saul R Powell1, Andras Divald.   

Abstract

The ubiquitin-proteasome system (UPS) represents the major pathway for degradation of intracellular proteins. This article reviews the major components and configurations of the UPS including the 26S proteasome and 11S activated proteasome relevant to myocardial ischaemia. We then present the evidence that the UPS is dysfunctional during myocardial ischaemia as well as potential consequences of this, including dysregulation of target substrates, many of them active signalling proteins, and accumulation of oxidized proteins. As part of this discussion, potential mechanisms, including ATP depletion, inhibition by insoluble protein aggregates, and oxidation of proteasome and regulatory particle subunits, are discussed. Finally, the evidence suggesting a role for the UPS in ischaemic preconditioning is presented. Much of this is inferential but clearly indicates the need for additional research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793765      PMCID: PMC2797450          DOI: 10.1093/cvr/cvp321

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  117 in total

Review 1.  The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core.

Authors:  W Heinemeyer; P C Ramos; R J Dohmen
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

2.  New insights into potential mechanisms of ischemic preconditioning.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

3.  Oxidative changes in hypoxic rat heart tissue.

Authors:  Y Park; S Kanekal; J P Kehrer
Journal:  Am J Physiol       Date:  1991-05

4.  Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.

Authors:  K J Davies; S W Lin; R E Pacifici
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

5.  Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure.

Authors:  K J Davies; M E Delsignore
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

Review 6.  Nucleotide metabolism and cellular damage in myocardial ischemia.

Authors:  R B Jennings; C Steenbergen
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 7.  Pathogenesis of cancer cachexia.

Authors:  Michael J Tisdale
Journal:  J Support Oncol       Date:  2003 Sep-Oct

Review 8.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease.

Authors:  Tilman Grune; Tobias Jung; Katrin Merker; Kelvin J A Davies
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

9.  Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo.

Authors:  Natalia A Osna; James Haorah; Viatcheslav M Krutik; Terrence M Donohue
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

10.  Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins.

Authors:  Igor Khaliulin; Herzl Schwalb; Ping Wang; Ester Houminer; Leonid Grinberg; Harvey Katzeff; Joseph B Borman; Saul R Powell
Journal:  Free Radic Biol Med       Date:  2004-07-01       Impact factor: 7.376

View more
  20 in total

Review 1.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

2.  Modulation of Na(+)-K(+)-ATPase cell surface abundance through structural determinants on the α1-subunit.

Authors:  Sandrine V Pierre; Aude Belliard; Yoann Sottejeau
Journal:  Am J Physiol Cell Physiol       Date:  2010-11-03       Impact factor: 4.249

Review 3.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Integrated microRNA and mRNA responses to acute human left ventricular ischemia.

Authors:  Louis A Saddic; Tzuu-Wang Chang; Martin I Sigurdsson; Mahyar Heydarpour; Benjamin A Raby; Stanton K Shernan; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

5.  The role of ubiquitin in cardiac ischemia-reperfusion injury.

Authors:  Motoi Kobayashi; Jason K Higa; Takashi Matsui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-18       Impact factor: 4.733

Review 6.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 7.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

8.  Upregulation of proteasome activity rescues cardiomyocytes following pulse treatment with a proteasome inhibitor.

Authors:  Ping Wang; Justine Calise; Keren Powell; Andras Divald; Saul R Powell
Journal:  Am J Cardiovasc Dis       Date:  2014-01-15

Review 9.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

Review 10.  The ubiquitin proteasome system in human cardiomyopathies and heart failure.

Authors:  Sharlene M Day
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.